0001127602-24-019998.txt : 20240703 0001127602-24-019998.hdr.sgml : 20240703 20240703131254 ACCESSION NUMBER: 0001127602-24-019998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mellion Michelle L CENTRAL INDEX KEY: 0001923040 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41374 FILM NUMBER: 241099152 MAIL ADDRESS: STREET 1: PEPGEN INC. STREET 2: 245 MAIN ST. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PepGen Inc. CENTRAL INDEX KEY: 0001835597 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 MARINA PARK DRIVE, SUITE 900 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 703-456-8000 MAIL ADDRESS: STREET 1: 1 MARINA PARK DRIVE, SUITE 900 CITY: BOSTON STATE: MA ZIP: 02210 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-07-01 0001835597 PepGen Inc. PEPG 0001923040 Mellion Michelle L 321 HARRISON AVE., 8TH FLOOR C/O PEPGEN INC. BOSTON MA 02118 1 Chief Medical Officer 1 Common Stock 2024-07-01 4 M 0 875 10.21 A 875 D Common Stock 2024-07-01 4 S 0 875 18.011 D 0 D Common Stock 2024-07-02 4 M 0 37 10.21 A 37 D Common Stock 2024-07-02 4 S 0 37 18.07 D 0 D Stock Option (Right to Buy) 10.21 2024-07-01 4 M 0 875 0 D 2032-06-30 Common Stock 875 79623 D Stock Option (Right to Buy) 10.21 2024-07-02 4 M 0 37 0 D 2032-06-30 Common Stock 37 79586 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. /s/ Noel Donnelly, as Attorney-in-Fact 2024-07-03